These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 31526775)
1. Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy. Evliyaoglu O; van Helden J; Jaruschewski S; Imöhl M; Weiskirchen R Clin Biochem; 2019 Dec; 74():42-46. PubMed ID: 31526775 [TBL] [Abstract][Full Text] [Related]
2. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. Katzmann JA; Snyder MR; Rajkumar SV; Kyle RA; Therneau TM; Benson JT; Dispenzieri A Clin Chem; 2011 Dec; 57(12):1687-92. PubMed ID: 21980167 [TBL] [Abstract][Full Text] [Related]
3. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920 [TBL] [Abstract][Full Text] [Related]
4. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma. Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439 [TBL] [Abstract][Full Text] [Related]
5. Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases. Dogaru M; Lazăr V; Coriu D Roum Arch Microbiol Immunol; 2012; 71(4):183-200. PubMed ID: 23755700 [TBL] [Abstract][Full Text] [Related]
6. Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Willrich MAV; Murray DL; Kyle RA Clin Biochem; 2018 Jan; 51():38-47. PubMed ID: 28479151 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution. Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181 [TBL] [Abstract][Full Text] [Related]
8. A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female. Fager Ferrari M; Lemonakis K; Förnvik Jonsson M Scand J Clin Lab Invest; 2021 Sep; 81(5):385-388. PubMed ID: 34097568 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma]. Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965 [TBL] [Abstract][Full Text] [Related]
10. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio. Levinson SS Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809 [TBL] [Abstract][Full Text] [Related]
11. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy. Wolff F; Thiry C; Willems D Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359 [TBL] [Abstract][Full Text] [Related]
13. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma. Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572 [TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [TBL] [Abstract][Full Text] [Related]
16. Prognostic utility of intact immunoglobulin Ig'κ/Ig'λ ratios in multiple myeloma patients. Bradwell A; Harding S; Fourrier N; Mathiot C; Attal M; Moreau P; Harousseau JL; Avet-Loiseau H Leukemia; 2013 Jan; 27(1):202-7. PubMed ID: 22699454 [TBL] [Abstract][Full Text] [Related]
17. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies. Cao F; Zhang R; Xu L; Liu M; Yuan Y Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System]. Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604 [TBL] [Abstract][Full Text] [Related]
20. Practical considerations for the measurement of free light chains in serum. Tate JR; Gill D; Cobcroft R; Hickman PE Clin Chem; 2003 Aug; 49(8):1252-7. PubMed ID: 12881439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]